Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Evotec Reports Third Quarter and Nine-Month 2026 Results: Building Growth Momentum Toward 2030 Goals
      Biotech

      Evotec Reports Third Quarter and Nine-Month 2026 Results: Building Growth Momentum Toward 2030 Goals

      November 5, 2026
      Nuvation Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
      Biotech

      Nuvation Bio Reports Third Quarter 2026 Financial Results and Provides Business Update

      November 5, 2026
      SERA PROGNOSTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
      Biotech

      SERA PROGNOSTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS

      November 5, 2026
      Precigen Reports Third Quarter 2026 Results Highlighted by Strong Sequential PAPZIMEOS Revenue Growth and Positive Cash Flow Ahead of Guidance
      Biotech

      Precigen Reports Third Quarter 2026 Results Highlighted by Strong Sequential PAPZIMEOS Revenue Growth and Positive Cash Flow Ahead of Guidance

      November 4, 2026
      Stocks Surged Across the Board Today, and Biotech Brought Its Own Earnings Story
      Biotech

      Stocks Surged Across the Board Today, and Biotech Brought Its Own Earnings Story

      November 4, 2026
      Vivoryon Therapeutics N.V. Reports Q3 2026 Financial Results  and Provides Business Update
      Biotech

      Vivoryon Therapeutics N.V. Reports Q3 2026 Financial Results and Provides Business Update

      November 4, 2026
      DRI Healthcare Reports Third Quarter 2026 Results
      Biotech

      DRI Healthcare Reports Third Quarter 2026 Results

      November 4, 2026
      Telix Joins Thera4Care with TLX400-Tx to Accelerate Translation of Next Generation FAP-Targeting Theranostics
      Biotech

      Telix Joins Thera4Care with TLX400-Tx to Accelerate Translation of Next Generation FAP-Targeting Theranostics

      November 4, 2026
      Compugen to Participate in November Investor Conferences
      Biotech

      Compugen to Participate in November Investor Conferences

      November 4, 2026
      HLS Therapeutics Partners with Bayer to Commercialize VERQUVO® in Canada
      Biotech

      HLS Therapeutics Partners with Bayer to Commercialize VERQUVO® in Canada

      November 4, 2026
      « 1 … 11 12 13 14 15 … 176 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026